Sustained Infrastructure Holdings, Inc. (2190)
XSAU 
Summary
2190 Chart
Sustained Infrastructure Holdings, Inc. (2190) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Sustained Infrastructure Holdings, Inc. ever had a stock split?
Sustained Infrastructure Holdings, Inc. Profile
| Health Care Technology Industry | Healthcare Sector | Dr. Zhong Zhao Ph.D. CEO | XSAU Exchange | SA0007879360 ISIN |
| DE Country | 875 Employees | 27 May 2026 Last Dividend | - Last Split | - IPO Date |
Overview
Zylox-Tonbridge Medical Technology Co., Ltd., established in 2012 and headquartered in Hangzhou, People's Republic of China, operates as a pioneering medical device company on both domestic and international fronts. The genesis of the company was under the name Zhejiang Zylox Medical Device Co., Ltd., which was later revised to its current designation in March 2021. Zylox-Tonbridge is dedicated to advancing the field of neuro- and peripheral-vascular interventional medical devices, leveraging its deep technical expertise to serve patients and physicians across the globe. In addition to producing cutting-edge medical devices, the company extends technical consultation and services, strengthening its position as a comprehensive provider in the healthcare sector. Furthermore, it engages in the importation of materials essential for its innovative product development processes.
Products and Services
Zylox-Tonbridge Medical Technology Co., Ltd. offers an expansive range of products and services tailored to meet the demanding needs of the neurovascular and peripheral-vascular interventional medicine sectors:
- Neurovascular Product Portfolio: Catering to a broad spectrum of conditions such as ischemic stroke, hemorrhagic stroke, intracranial stenosis, and carotid artery diseases. This portfolio encompasses a suite of products, including intracranial access devices, aimed at addressing the complex requirements of neurovascular interventions.
- Peripheral-Vascular Interventional Product Portfolio: Offers a comprehensive array of products for arterial and venous interventions. This includes stents, balloons, catheters, and filters designed for precision and efficacy. The portfolio also extends to hemodialysis access, aortic interventions, peripheral embolization interventions, and radiological intervention products, showcasing the company's commitment to diverse aspects of vascular health.
- Technical Consultation and Services: Beyond its product offerings, Zylox-Tonbridge plays a pivotal role in the medical community through its provision of expert technical consultation and services. This not only demonstrates their dedication to supporting medical professionals but also ensures that patients receive care that is informed by the latest advancements in medical technology.
